Pharma Journalist -

Amgen and Generate Biomedicines announced a research collaboration agreement to discover and create protein therapeutics for five clinical targets across several therapeutic areas and…
Read More...

TRexBio Inc., a discovery stage company decoding tissue immune biology to create revolutionary therapeutics, announced that it has entered into a multi-year research collaboration and…
Read More...

SMi Reports: Event Announcement: Transdermal and Microneedle Drug Delivery, January 12-13th January 2021 is now 3weeks away and is a virtual event. Access will be fully online…
Read More...

In the run up to our series of 2022 Pre-filled Syringes and Injectable Drug Delivery group of conferences taking place worldwide over the course of 2022, we at SMi undertook a survey…
Read More...

Pfizer Inc. and BioNTech SE announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles…
Read More...

SRI International (SRI) announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV (Janssen), one of the Janssen Pharmaceutical Companies of Johnson…
Read More...

NRx Pharmaceuticals announced that it has submitted an application for Emergency Use Authorization (EUA) to the US Food and Drug Administration (FDA) for the use of ZYESAMI (aviptadil)…
Read More...

Biogen Inc. and Ionis Pharmaceuticals, Inc. announced that Biogen exercised its option to obtain from Ionis a worldwide, exclusive, royalty-bearing license to develop and commercialize…
Read More...

SMi Group reports: Head of HBP Surgery and Co-Founder of MiNA Therapeutics, Nagy Habib discusses the challenges and developments in the RNA industry The RNA therapeutics industry has…
Read More...

Verseau Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug (IND) application for its lead investigational…
Read More...